| 000 | 01494nam a2200421 a 4500 | ||
|---|---|---|---|
| 005 | 20250918172019.0 | ||
| 008 | 121129s2012 xxka 001 0 eng | ||
| 020 |
_a9780521766067 _cRM275.32 |
||
| 039 | 9 |
_a201409261211 _bzainol _c201303211136 _dzaleha _c201303181207 _dIzzati _y11-29-2012 _zIzzati |
|
| 040 |
_dUKM _erda |
||
| 090 | _aQV76.5.E781 2012 9HUKM | ||
| 090 |
_aQV76.5 _b.E781 2012 9HUKM |
||
| 090 |
_aQV76.5 _b.E781 2012 9 |
||
| 245 | 0 | 0 |
_aEssential CNS drug development / _cedited by Amir Kalali [and three others] |
| 264 | 1 |
_aCambridge : _bCambridge University Press, _c2012. |
|
| 300 |
_ax, 207 p. : _billustration ; _c24 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aCambridge medicine | |
| 650 | 2 |
_aCentral Nervous System Agents _xpharmacology. |
|
| 650 | 2 |
_aClinical Trials as Topic _xmethods. |
|
| 650 | 2 |
_aDrug evaluation _xMethods. |
|
| 650 | 2 |
_aDrug Evaluation, Preclinical _xmethods. |
|
| 700 | 1 |
_aKalali, Amir _eeditor |
|
| 700 | 1 |
_aPreskorn, Sheldon _eeditor |
|
| 700 | 1 |
_aKwentus, Joseph _eeditor |
|
| 700 | 1 |
_aStahl, Stephen M. _eeditor |
|
| 830 | 0 | _aCambridge medicine. | |
| 907 |
_a.b15531193 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV76.5.E781 2012 9HUKM |
||
| 914 | _avtls003518829 | ||
| 990 | _aizzati/za | ||
| 991 | _aJabatan Psikiatri, PPUKM | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _ah _b2012-03-11 _cm _da _feng _gxxk _y0 _z.b15531193 |
||
| 999 |
_c536121 _d536121 |
||